Format

Send to

Choose Destination
Clin Immunol. 2013 Nov;149(2):225-35. doi: 10.1016/j.clim.2013.05.006. Epub 2013 May 23.

Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy.

Author information

1
Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Abstract

Women of childbearing age are at risk for developing systemic rheumatic diseases. Pregnancy can be challenging to manage in patients with rheumatic diseases for a variety of reasons including the impact of physiological and immunological changes of pregnancy on underlying disease activity, the varied presentation of rheumatic disease during pregnancy, and the limited treatment options. Previously, patients with rheumatic disease were often advised against pregnancy due to concerns of increased maternal and fetal morbidity and mortality. However, recent advancements in the understanding of the interaction between pregnancy and rheumatic disease have changed how we counsel patients. Patients with rheumatic disease can have successful pregnancy outcomes, particularly when a collaborative approach between the rheumatologist and obstetrician is applied. This review aims to discuss the effect of pregnancy on patients with the most common rheumatic diseases, the effect of these diseases on the pregnancy itself, and the management of these patients during pregnancy.

KEYWORDS:

Fertility; Pregnancy; Rheumatoid arthritis; Systemic lupus erythematosus; Treatment

PMID:
23773975
DOI:
10.1016/j.clim.2013.05.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center